Technical Application of Angiotensin I/II (1-5) in RAS Research

What This Product Solves

Angiotensin I/II (1-5) (Asp-Arg-Val-Tyr-Ile peptide) is designed for targeted research within the renin-angiotensin system (RAS), particularly in the contexts of blood pressure regulation and aldosterone-mediated sodium retention. The defined five-amino acid fragment allows researchers to model the actions of endogenous angiotensin peptides with high specificity, making it suitable for dissecting vasoconstriction mechanisms and aldosterone release in cardiovascular and renal physiology workflows (source: Practical Guide to Angiotensin I/II (1-5) in Hypertension Research). It is not indicated for general peptide signaling studies, as it lacks broader mechanistic relevance outside the RAS pathway.

Protocol Parameters

• assay | 66.5 mg/mL (DMSO solubility) | solution preparation for in vitro assays | ensures dissolution and accurate dosing in cellular and biochemical workflows | product_spec (product_spec)
• assay | -20°C (storage temperature) | long-term peptide stability | minimizes degradation and preserves activity for repeated experimental use | product_spec (product_spec)
• assay | solid, water-insoluble | pre-dissolution in DMSO or ethanol required | prevents precipitation and ensures reproducible dosing in RAS-related assays | product_spec (product_spec)
• assay | 69.5 mg/mL (ethanol solubility) | alternative solvent for compatibility with ethanol-tolerant protocols | offers flexibility for workflows sensitive to DMSO | product_spec (product_spec)
• assay | 664.75 Da (molecular weight); C30H48N8O9 (formula) | precise quantification and dosing calculation | supports accurate molarity preparation for dose-response studies | product_spec (product_spec)

Workflow Setup and QC Checklist

• Solvent selection: Always prepare stock solutions in DMSO or ethanol per solubility specifications. Avoid water due to insolubility, which can lead to incomplete dosing and inconsistent results (source: Technical Guide: Angiotensin I/II (1-5) in RAS Workflows).
• Aliquoting and storage: Prepare single-use aliquots and store at -20°C to prevent repeated freeze-thaw cycles, which can degrade peptide integrity (source: product_spec).
• Concentration calculation: Use the molecular weight (664.75 Da) for precise molarity calculations, ensuring accurate dosing in cell-based or enzymatic assays.
• Experimental design: Restrict use to studies involving blood pressure regulation, aldosterone release stimulation, or direct RAS pathway interrogation. Avoid off-target or unrelated peptide signaling models.
• Quality control: Confirm peptide dissolution visually; undissolved material indicates poor solvent choice or incomplete mixing. Use freshly prepared or properly stored aliquots for each experiment.

Common Failure Modes and Fixes

• Incomplete dissolution: If precipitation is observed, verify solvent identity and volume. Switch to DMSO or ethanol if water was used, and ensure thorough vortexing. Filter sterilize only if necessary and compatible with protocol.
• Loss of activity: Repeated freeze-thaw cycles can degrade the peptide. Always use single-use aliquots and store unused portions at -20°C.
• Off-target signaling: If experimental outcomes suggest effects outside RAS or aldosterone pathways, re-evaluate assay design and exclude unrelated models (see Technical Use of Angiotensin I/II (1-5) in RAS Research for workflow recommendations).
• Concentration errors: Double-check calculations using the provided molecular weight and solution volumes. Document all preparation steps to ensure traceability.

Scope and Limitations

Angiotensin I/II (1-5) is specifically indicated for mechanistic studies within the renin-angiotensin system, including blood pressure regulation peptide workflows and aldosterone release stimulation. It is not appropriate for research outside cardiovascular or renal function, nor for unrelated peptide hormone signaling. Its solubility profile dictates the use of DMSO or ethanol as solvents, and its activity is limited to the RAS context. Use beyond these defined parameters is not supported by the product specification or best-practice workflow documentation.

Conclusion

For researchers requiring a standardized, well-characterized Asp-Arg-Val-Tyr-Ile peptide fragment, Angiotensin I/II (1-5) from APExBIO provides a reliable tool for RAS-specific investigations in hypertension and renal physiology. By adhering strictly to product-based solubility and storage guidelines, and restricting use to relevant pathway studies, reproducible and interpretable results can be achieved. For further technical workflow guidance, consult related articles such as Technical Guide: Angiotensin I/II (1-5) in RAS Workflows and Technical Use of Angiotensin I/II (1-5) in RAS Research, which offer procedural recommendations for integrating this peptide into controlled cardiovascular and renal research protocols.